Embed Size (px)
Citation preview
www.artes-biotechnology.com
BioSimilarstechnology transfer
Hirudin
Hepatitis B vaccine
HPV vaccine
Interferon alpha 2a
Interferon alpha 2b
Insulin
Hirulog
Para Thyroid Hormone
… request for more!
CPHi-Folder.indd 3 22.09.14 17:17
Advantages:
GRAS low-cost expression platform
stable production cell lines
no expensive inducer like MeOH or IPTG
complete production process
full documentation technology transfer
We are the dedicated partner for your biosimilar product!
Products manufactured from our platform have gained approval by EMEA, US-FDA, WHO and EFSA.
Processes are implemented at manufacturing sites in India (6), Indonesia (1), Thailand (2), Egypt, (2) Argentina (1) and South Korea (1).
ARTES Biotechnology GmbHElisabeth-Selbert-Str. 9, 40764 Langenfeld, Germany, +49 (0) 2173 27587 0www. artes-biotechnology.com, [email protected]
ARTES continuously develops valuable biosimilar processes. All of them excel with safe, fast and efficient production features.
Our cell lines and processes provide lower cost-of-goods and higher stability than originator and competitor processes.
ARTES’ experienced technology transfer team is dedicated to support you for smooth implementation at your manufacturing site.
CPHi-Folder.indd 4 22.09.14 17:17
